|
2008-11-24 |
2008-11-21 |
S
Sale
|
ICAHN CARL C
Non-Executive Director
Large shareholder
|
11,669,544
-100.0%
70.00
USD 816,868,080
|
11,669,544
-100.0%
|
70.00
|
USD 816,868,080
|
|
|
2008-11-07 |
2008-11-03 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
11,957
-87.1%
68.72
USD 821,685
|
11,957
-87.1%
|
68.72
|
USD 821,685
|
|
|
2008-09-04 |
2008-09-02 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
11,957
-87.1%
64.40
USD 770,031
|
11,957
-87.1%
|
64.40
|
USD 770,031
|
|
|
2008-08-01 |
2008-07-31 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
15,000
-89.4%
64.16
USD 962,400
|
15,000
-89.4%
|
64.16
|
USD 962,400
|
|
|
2008-08-01 |
2007-11-19 |
PS
Planned sale
|
BAILEY MICHAEL P
SVP, Commercial Ops
Officer
|
14,750
-87.9%
64.16
USD 946,291
|
14,750
-87.9%
|
64.16
|
USD 946,291
|
|
|
2008-08-01 |
2007-11-19 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
11,957
-87.1%
64.16
USD 767,161
|
11,957
-87.1%
|
64.16
|
USD 767,161
|
|
|
2007-11-21 |
2007-11-19 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
3,150
-100.0%
42.65
USD 134,348
|
3,150
-100.0%
|
42.65
|
USD 134,348
|
|
|
2007-11-21 |
2007-11-19 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
6,000
-100.0%
42.65
USD 255,900
|
6,000
-100.0%
|
42.65
|
USD 255,900
|
|
|
2007-09-10 |
2007-09-07 |
B
Purchase
|
Johnson John H
CEO
Officer
|
13,609
+inf%
36.74
USD 499,995
|
13,609
+inf%
|
36.74
|
USD 499,995
|
|
|
2007-07-13 |
2007-07-12 |
PS
Planned sale
|
BAILEY MICHAEL P
SVP, Commercial Ops
Officer
|
1,250
-100.0%
34.20
USD 42,750
|
1,250
-100.0%
|
34.20
|
USD 42,750
|
|
|
2006-10-16 |
2006-10-13 |
S
Sale
|
RAMANATHAN ERIK
Senior Vice President, Legal
Officer
|
9,996
-100.0%
30.90
USD 308,876
|
9,996
-100.0%
|
30.90
|
USD 308,876
|
|
|
2006-10-12 |
2006-10-10 |
S
Sale
|
RAMANATHAN ERIK
Senior Vice President, Legal
Officer
|
5,004
-100.0%
30.92
USD 154,734
|
5,004
-100.0%
|
30.92
|
USD 154,734
|
|
|
2006-10-10 |
2006-10-05 |
S
Sale
|
HOWERTON MICHAEL
SVP, Chief Financial Officer
Officer
|
436
-100.0%
29.33
USD 12,790
|
436
-100.0%
|
29.33
|
USD 12,790
|
|
|
2006-10-10 |
2006-10-05 |
S
Sale
|
HOWERTON MICHAEL
SVP, Chief Financial Officer
Officer
|
10,000
-95.8%
29.33
USD 293,340
|
10,000
-95.8%
|
29.33
|
USD 293,340
|
|
|
2006-09-15 |
2006-09-14 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
25,088
+0.2%
30.15
USD 756,403
|
25,088
+0.2%
|
30.15
|
USD 756,403
|
|
|
2006-09-15 |
2006-09-14 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
16,112
+0.1%
30.15
USD 485,777
|
16,112
+0.1%
|
30.15
|
USD 485,777
|
|
|
2006-09-15 |
2006-09-13 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
365,358
+3.2%
29.91
USD 10,927,858
|
365,358
+3.2%
|
29.91
|
USD 10,927,858
|
|
|
2006-09-15 |
2006-09-13 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
234,642
+2.1%
29.91
USD 7,018,142
|
234,642
+2.1%
|
29.91
|
USD 7,018,142
|
|
|
2006-08-30 |
2006-08-28 |
S
Sale
|
RAMANATHAN ERIK
SVP, Secretary & Gen Counsel
Officer
|
5,000
-33.8%
30.19
USD 150,948
|
5,000
-33.8%
|
30.19
|
USD 150,948
|
|
|
2006-08-28 |
2006-08-28 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
9,588
+0.1%
30.12
USD 288,791
|
9,588
+0.1%
|
30.12
|
USD 288,791
|
|
|
2006-08-28 |
2006-08-28 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
6,157
+0.1%
30.12
USD 185,449
|
6,157
+0.1%
|
30.12
|
USD 185,449
|
|
|
2006-08-29 |
2006-08-25 |
S
Sale
|
HOWERTON MICHAEL
SVP, Chief Financial Officer
Officer
|
6,250
-93.5%
30.01
USD 187,592
|
6,250
-93.5%
|
30.01
|
USD 187,592
|
|
|
2006-08-28 |
2006-08-25 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
40,740
+0.4%
29.98
USD 1,221,385
|
40,740
+0.4%
|
29.98
|
USD 1,221,385
|
|
|
2006-08-28 |
2006-08-25 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
26,164
+0.2%
29.98
USD 784,397
|
26,164
+0.2%
|
29.98
|
USD 784,397
|
|
|
2006-08-28 |
2006-08-24 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
55,560
+0.5%
29.98
USD 1,665,689
|
55,560
+0.5%
|
29.98
|
USD 1,665,689
|
|
|
2006-08-28 |
2006-08-24 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
35,682
+0.3%
29.98
USD 1,069,746
|
35,682
+0.3%
|
29.98
|
USD 1,069,746
|
|
|
2006-08-23 |
2006-08-22 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
60,893
+0.6%
29.99
USD 1,826,181
|
60,893
+0.6%
|
29.99
|
USD 1,826,181
|
|
|
2006-08-23 |
2006-08-22 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
46,304
+0.4%
29.97
USD 1,387,731
|
46,304
+0.4%
|
29.97
|
USD 1,387,731
|
|
|
2006-08-23 |
2006-08-22 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
39,107
+0.4%
29.99
USD 1,172,819
|
39,107
+0.4%
|
29.99
|
USD 1,172,819
|
|
|
2006-08-23 |
2006-08-22 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
29,738
+0.3%
29.97
USD 891,248
|
29,738
+0.3%
|
29.97
|
USD 891,248
|
|
|
2006-08-23 |
2006-08-21 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
14,005
+0.1%
29.96
USD 419,590
|
14,005
+0.1%
|
29.96
|
USD 419,590
|
|
|
2006-08-23 |
2006-08-21 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
8,995
+0.1%
29.96
USD 269,490
|
8,995
+0.1%
|
29.96
|
USD 269,490
|
|
|
2006-08-18 |
2006-08-18 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
72,577
+0.7%
29.97
USD 2,175,133
|
72,577
+0.7%
|
29.97
|
USD 2,175,133
|
|
|
2006-08-18 |
2006-08-18 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
46,610
+0.4%
29.97
USD 1,396,902
|
46,610
+0.4%
|
29.97
|
USD 1,396,902
|
|
|
2006-08-18 |
2006-08-17 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
46,949
+0.4%
29.55
USD 1,387,343
|
46,949
+0.4%
|
29.55
|
USD 1,387,343
|
|
|
2006-08-18 |
2006-08-17 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
30,151
+0.3%
29.55
USD 890,962
|
30,151
+0.3%
|
29.55
|
USD 890,962
|
|
|
2006-08-18 |
2006-08-16 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
63,464
+0.6%
28.96
USD 1,837,917
|
63,464
+0.6%
|
28.96
|
USD 1,837,917
|
|
|
2006-08-18 |
2006-08-16 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
40,758
+0.4%
28.96
USD 1,180,352
|
40,758
+0.4%
|
28.96
|
USD 1,180,352
|
|
|
2006-08-15 |
2006-08-15 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
104,028
+1.0%
28.46
USD 2,960,637
|
104,028
+1.0%
|
28.46
|
USD 2,960,637
|
|
|
2006-08-15 |
2006-08-15 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
161,981
+1.6%
28.46
USD 4,609,979
|
161,981
+1.6%
|
28.46
|
USD 4,609,979
|
|
|
2006-08-15 |
2006-08-14 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
152,232
+1.5%
28.67
USD 4,364,491
|
152,232
+1.5%
|
28.67
|
USD 4,364,491
|
|
|
2006-08-15 |
2006-08-14 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
97,768
+1.0%
28.67
USD 2,803,009
|
97,768
+1.0%
|
28.67
|
USD 2,803,009
|
|
|
2006-08-15 |
2006-08-11 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
612,766
+6.6%
27.89
USD 17,090,044
|
612,766
+6.6%
|
27.89
|
USD 17,090,044
|
|
|
2006-08-15 |
2006-08-11 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
393,534
+4.5%
27.89
USD 10,975,663
|
393,534
+4.5%
|
27.89
|
USD 10,975,663
|
|
|
2006-08-15 |
2006-08-11 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
75,581
+0.9%
27.83
USD 2,103,419
|
75,581
+0.9%
|
27.83
|
USD 2,103,419
|
|
|
2006-08-15 |
2006-08-11 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
48,540
+0.6%
27.83
USD 1,350,868
|
48,540
+0.6%
|
27.83
|
USD 1,350,868
|
|
|
2006-08-07 |
2006-08-04 |
S
Sale
|
MARTELL RON
Former SVP, Commercial Ops
Officer
|
9,000
-80.0%
33.48
USD 301,285
|
9,000
-80.0%
|
33.48
|
USD 301,285
|
|
|
2006-08-07 |
2006-08-03 |
S
Sale
|
MARTELL RON
Former SVP, Commercial Ops
Officer
|
14,284
-86.4%
33.06
USD 472,258
|
14,284
-86.4%
|
33.06
|
USD 472,258
|
|
|
2006-08-07 |
2006-08-03 |
S
Sale
|
MARTELL RON
Former SVP, Commercial Ops
Officer
|
4,624
-67.3%
33.06
USD 152,879
|
4,624
-67.3%
|
33.06
|
USD 152,879
|
|
|
2006-07-05 |
2006-07-03 |
PS
Planned sale
|
DEVITA VINCENT
Non-Executive Director
|
5,000
-8.0%
38.77
USD 193,850
|
5,000
-8.0%
|
38.77
|
USD 193,850
|
|
|
2006-07-05 |
2006-07-03 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
1,000
-100.0%
38.68
USD 38,676
|
1,000
-100.0%
|
38.68
|
USD 38,676
|
|
|
2006-06-23 |
2006-06-21 |
PS
Planned sale
|
RAMANATHAN ERIK
SVP, Secretary & Gen Counsel
Officer
|
1,250
-11.3%
40.00
USD 50,000
|
1,250
-11.3%
|
40.00
|
USD 50,000
|
|
|
2006-06-05 |
2006-06-01 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
1,000
-100.0%
39.84
USD 39,840
|
1,000
-100.0%
|
39.84
|
USD 39,840
|
|
|
2006-06-05 |
2006-06-01 |
PS
Planned sale
|
DEVITA VINCENT
Non-Executive Director
|
5,000
-8.0%
39.92
USD 199,591
|
5,000
-8.0%
|
39.92
|
USD 199,591
|
|
|
2006-05-17 |
2006-05-15 |
B
Purchase
|
TARNOWSKI S JOSEPH
FORMER SVP, MFG, PD & OPS
|
1,594
+5.7%
42.14
USD 67,171
|
1,594
+5.7%
|
42.14
|
USD 67,171
|
|
|
2006-05-17 |
2006-05-15 |
B
Purchase
|
TARNOWSKI S JOSEPH
FORMER SVP, MFG, PD & OPS
|
100
+0.4%
42.13
USD 4,213
|
100
+0.4%
|
42.13
|
USD 4,213
|
|
|
2006-05-17 |
2006-05-15 |
B
Purchase
|
TARNOWSKI S JOSEPH
FORMER SVP, MFG, PD & OPS
|
600
+2.2%
42.12
USD 25,272
|
600
+2.2%
|
42.12
|
USD 25,272
|
|
|
2006-05-17 |
2006-05-15 |
B
Purchase
|
TARNOWSKI S JOSEPH
FORMER SVP, MFG, PD & OPS
|
1,206
+4.6%
42.10
USD 50,773
|
1,206
+4.6%
|
42.10
|
USD 50,773
|
|
|
2006-05-16 |
2006-05-12 |
PS
Planned sale
|
HOWERTON MICHAEL
SVP, Chief Financial Officer
Officer
|
2,800
-86.5%
40.00
USD 112,000
|
2,800
-86.5%
|
40.00
|
USD 112,000
|
|
|
2006-05-11 |
2006-05-10 |
PS
Planned sale
|
HOWERTON MICHAEL
SVP, Chief Financial Officer
Officer
|
2,200
-83.5%
40.00
USD 88,000
|
2,200
-83.5%
|
40.00
|
USD 88,000
|
|
|
2006-05-09 |
2006-05-05 |
B
Purchase
|
ICAHN CARL C ET AL
Large shareholder
|
47,527
+0.6%
37.27
USD 1,771,331
|
47,527
+0.6%
|
37.27
|
USD 1,771,331
|
|
|
2006-05-03 |
2006-05-01 |
PS
Planned sale
|
DEVITA VINCENT
Non-Executive Director
|
5,000
-8.0%
36.04
USD 180,190
|
5,000
-8.0%
|
36.04
|
USD 180,190
|
|
|
2006-05-03 |
2006-05-01 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
1,000
-100.0%
35.96
USD 35,960
|
1,000
-100.0%
|
35.96
|
USD 35,960
|
|
|
2006-04-24 |
2006-04-24 |
B
Purchase
|
TARNOWSKI S JOSEPH
FORMER SVP, MFG, PD & OPS
|
6,500
+32.8%
37.16
USD 241,540
|
6,500
+32.8%
|
37.16
|
USD 241,540
|
|
|
2006-04-24 |
2006-04-21 |
PS
Planned sale
|
CROWLEY Richard
SVP, Biopharmaceutical Ops
Officer
|
1,000
-100.0%
35.00
USD 35,000
|
1,000
-100.0%
|
35.00
|
USD 35,000
|
|
|
2006-04-19 |
2006-04-17 |
PS
Planned sale
|
FAZIO JOHN A
Non-Executive Director
|
3,000
-100.0%
32.82
USD 98,453
|
3,000
-100.0%
|
32.82
|
USD 98,453
|
|
|
2006-04-14 |
2006-04-12 |
S
Sale
|
MARTELL RON
SVP, Commercial Operations
Officer
|
5,585
-47.2%
32.97
USD 184,130
|
5,585
-47.2%
|
32.97
|
USD 184,130
|
|
|
2006-04-06 |
2006-04-04 |
PS
Planned sale
|
DEVITA VINCENT
Non-Executive Director
|
5,000
-8.0%
35.00
USD 175,000
|
5,000
-8.0%
|
35.00
|
USD 175,000
|
|
|
2006-03-22 |
2006-03-20 |
PS
Planned sale
|
DEVITA VINCENT
Non-Executive Director
|
5,000
-8.0%
34.50
USD 172,500
|
5,000
-8.0%
|
34.50
|
USD 172,500
|
|
|
2006-03-22 |
2006-03-20 |
PS
Planned sale
|
DEVITA VINCENT
Non-Executive Director
|
5,000
-8.0%
34.50
USD 172,500
|
5,000
-8.0%
|
34.50
|
USD 172,500
|
|
|
2006-03-03 |
2006-03-02 |
B
Purchase
|
TARNOWSKI S JOSEPH
FORMER SVP, MFG, PD & OPS
|
1,000
+10.0%
38.19
USD 38,190
|
1,000
+10.0%
|
38.19
|
USD 38,190
|
|
|
2006-02-01 |
2006-01-30 |
S
Sale
|
DEVITA VINCENT
Non-Executive Director
|
14,000
-19.6%
35.85
USD 501,844
|
14,000
-19.6%
|
35.85
|
USD 501,844
|
|
|
2006-02-01 |
2006-01-30 |
S
Sale
|
DEVITA VINCENT
Non-Executive Director
|
5,000
-8.0%
35.85
USD 179,230
|
5,000
-8.0%
|
35.85
|
USD 179,230
|
|
|
2006-01-19 |
2006-01-17 |
PS
Planned sale
|
TARNOWSKI S JOSEPH
SVP, Manufacturing, Ops & PD
Officer
|
1,000
-9.1%
35.00
USD 35,000
|
1,000
-9.1%
|
35.00
|
USD 35,000
|
|
|
2005-12-29 |
2005-12-27 |
PS
Planned sale
|
TARNOWSKI S JOSEPH
SVP, Manufacturing, Ops & PD
Officer
|
2,000
-16.7%
35.00
USD 70,000
|
2,000
-16.7%
|
35.00
|
USD 70,000
|
|
